GHRL and gastric neuroendocrine tumor, well differentiated, low or intermediate grade: Although the expression of obestatin was described in human gastric neuroendocrine tumors [9, 10], no studies have provided evidence of the obestatin/GPR39 expression in other types of gastric cancer, especially adenocarcinomas, or the functional role of this system in these cancers.